Hydrogenerede rapamycinderivater
A derivarive of rapamycin where one, two, or three of the double bonds at the 1-, 3-, or 5-positions of rapamiycin have been reduced to the corresponding alkane, or a pharmaceutically acceptable salt thereof, which by virtue of its antifungal activity is useful in treating fungal infections.
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | dan |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CAUFIELD, CRAIG EUGENE RINKER, JAMES MICHAEL MUSSER, JOHN HENRY |
| description | A derivarive of rapamycin where one, two, or three of the double bonds at the 1-, 3-, or 5-positions of rapamiycin have been reduced to the corresponding alkane, or a pharmaceutically acceptable salt thereof, which by virtue of its antifungal activity is useful in treating fungal infections. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK0475577TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK0475577TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK0475577TT33</originalsourceid><addsrcrecordid>eNrjZFDwqEwpyk9PzUstSk1JVShKLEjMrUzOzEtJLcosSyxJLeJhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJQL0l8S7eBibmpqbm5iEhxsbEqAEApjEmbA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Hydrogenerede rapamycinderivater</title><source>esp@cenet</source><creator>CAUFIELD, CRAIG EUGENE ; RINKER, JAMES MICHAEL ; MUSSER, JOHN HENRY</creator><creatorcontrib>CAUFIELD, CRAIG EUGENE ; RINKER, JAMES MICHAEL ; MUSSER, JOHN HENRY</creatorcontrib><description>A derivarive of rapamycin where one, two, or three of the double bonds at the 1-, 3-, or 5-positions of rapamiycin have been reduced to the corresponding alkane, or a pharmaceutically acceptable salt thereof, which by virtue of its antifungal activity is useful in treating fungal infections.</description><edition>5</edition><language>dan</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>1994</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19940425&DB=EPODOC&CC=DK&NR=0475577T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19940425&DB=EPODOC&CC=DK&NR=0475577T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CAUFIELD, CRAIG EUGENE</creatorcontrib><creatorcontrib>RINKER, JAMES MICHAEL</creatorcontrib><creatorcontrib>MUSSER, JOHN HENRY</creatorcontrib><title>Hydrogenerede rapamycinderivater</title><description>A derivarive of rapamycin where one, two, or three of the double bonds at the 1-, 3-, or 5-positions of rapamiycin have been reduced to the corresponding alkane, or a pharmaceutically acceptable salt thereof, which by virtue of its antifungal activity is useful in treating fungal infections.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1994</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDwqEwpyk9PzUstSk1JVShKLEjMrUzOzEtJLcosSyxJLeJhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJQL0l8S7eBibmpqbm5iEhxsbEqAEApjEmbA</recordid><startdate>19940425</startdate><enddate>19940425</enddate><creator>CAUFIELD, CRAIG EUGENE</creator><creator>RINKER, JAMES MICHAEL</creator><creator>MUSSER, JOHN HENRY</creator><scope>EVB</scope></search><sort><creationdate>19940425</creationdate><title>Hydrogenerede rapamycinderivater</title><author>CAUFIELD, CRAIG EUGENE ; RINKER, JAMES MICHAEL ; MUSSER, JOHN HENRY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK0475577TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>1994</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>CAUFIELD, CRAIG EUGENE</creatorcontrib><creatorcontrib>RINKER, JAMES MICHAEL</creatorcontrib><creatorcontrib>MUSSER, JOHN HENRY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CAUFIELD, CRAIG EUGENE</au><au>RINKER, JAMES MICHAEL</au><au>MUSSER, JOHN HENRY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Hydrogenerede rapamycinderivater</title><date>1994-04-25</date><risdate>1994</risdate><abstract>A derivarive of rapamycin where one, two, or three of the double bonds at the 1-, 3-, or 5-positions of rapamiycin have been reduced to the corresponding alkane, or a pharmaceutically acceptable salt thereof, which by virtue of its antifungal activity is useful in treating fungal infections.</abstract><edition>5</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | dan |
| recordid | cdi_epo_espacenet_DK0475577TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | Hydrogenerede rapamycinderivater |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T00%3A58%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CAUFIELD,%20CRAIG%20EUGENE&rft.date=1994-04-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK0475577TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |